Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

42.26. Analysis.

42.26

Comparison 42 Adverse events within six months: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD), Outcome 26 Pharyngitis (non‐infectious).